Crossmark

Laboratory features and pharmacological management of early and late-onset primary Sjögren’s syndrome

Crossref DOI link: https://doi.org/10.1007/s00296-024-05626-0

Published Online: 2024-06-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saleem, Rimah A. https://orcid.org/0000-0002-4654-245X
Ramadan, Majed https://orcid.org/0000-0001-9838-2155
Elshaaer, Yasmin https://orcid.org/0009-0007-2675-7211
Sukkarieh, Hatouf https://orcid.org/0000-0003-3736-5989
Alissa, Rasha https://orcid.org/0009-0005-2356-9069
Alhusseini, Noara https://orcid.org/0000-0003-4976-4194
Tamim, Hani https://orcid.org/0000-0002-2019-4362
Alshahrani, Awad https://orcid.org/0000-0001-8266-6145
Almaimoni, Hesham https://orcid.org/0009-0003-2577-6868
License Information

Text and Data Mining valid from 2024-06-05

Version of Record valid from 2024-06-05
More Information

Article History

Received: 24 February 2024

Accepted: 29 April 2024

First Online: 5 June 2024

Declarations

:

: The authors declare no conflict.

: This study was made freely available through Open Access funding.